Cipro is effective in relieving dizziness caused by some cervical spondylosis, and is often used to treat dizziness caused by insufficient blood supply to the vertebrobasilar artery and high blood viscosity in patients with cervical spondylosis. However, Cipro is not a drug dedicated to the treatment of cervical spondylosis, but a vasodilator drug with the main indications of migraine, cerebral blood supply deficiency and cerebral thrombosis. On the one hand, Ciprolin can release the spasmodic constriction of blood vessels and increase blood flow without affecting the patient’s heart rate and blood pressure, thus improving the cerebral blood and oxygen supply. It has a therapeutic effect on dizziness caused by insufficient blood supply to the vertebrobasilar artery in patients with cervical spondylosis due to lesions of the vertebral artery, or stimulation or compression of the blood vessels causing stenosis or malformation. On the other hand, if patients with cervical spondylosis have tortuous, displaced or even high pressure vertebral arteries, they often have a tendency to have highly viscous blood, resulting in slowed cerebral blood flow and reduced flow, thus causing dizziness. Cipro can inhibit the influx of calcium ions into red blood cells and increase the deformation ability of red blood cells, which can reduce blood viscosity and increase cerebral blood flow, thus increasing the oxygen supply to brain tissues and significantly improving patients’ dizziness and headache. Although Cipro is effective in relieving the dizziness of some patients with cervical spondylosis, it cannot achieve the purpose of root cause. Patients should also be advised to combine treatment with other drugs. Clinical anti-inflammatory and analgesic drugs such as ibuprofen and etoricoxib are mostly used, and if necessary, surgical treatment is required in hospitals.